LIPAC Oncology LLC is a clinical-stage oncology company that develops precision targeted, locally delivered taxane technology platforms for localized cancer tumors. Its product pipeline targets medical conditions with high unmet needs, including bladder cancer, malignant pleural effusion, upper tract urothelial carcinoma, ovarian cancer, and intraperitoneal carcinoma.
Subscribe to see LIPAC Oncology LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
LIPAC Oncology LLC is a biotechnology company headquartered in United States. Its most recent funding round raised $372,500 in January 2020. Xcout tracks 4 named people at LIPAC Oncology LLC, including Ramachandran “TR” Thirucote (chairman & chief EXECUTIVE officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $372,500 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.